OGN

#1694
Organon & Co.
7.2950
+1.39%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
7.2550
7.3350
Jahresspanne
6.1900
9.9400
Tagesänderung
+1.39%
Monatliche Änderung
-18.26%
6 month change
+0.48%
Jahresänderung
+0.48%
Vorheriger Schlusskurs
7.1950
Open
7.2600
Bid
Ask
Low
7.2550
High
7.3350
Volumen
1 318
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.893 B
  • Employee 10 K
  • Founded N/A
  • CEO N/A
  • Website www.organon.com
  • Headquarter New Jersey, United States
  • FIGI BBG00ZQRGW24
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.96
Price to sales ratio
0.3
Dividends per share
0.34
Dividend yield %
4.74

Organon & Co

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

Nachrichten